Innoviva (INVA) Long-Term Investments (2012 - 2026)

Innoviva (INVA) posted Long-Term Investments of $413.1 million for Q1 2026, up 2.12% on a QoQ basis from $404.5 million in Q4 2025, and up 41.9% year-over-year from $291.1 million in Q1 2025.

Innoviva (INVA) Long-Term Investments (2012 - 2026) Analysis & Trends

Innoviva's Long-Term Investments history runs 11 years deep, the most recent figure standing at $413.1 million for Q1 2026.

  • Quarterly Long-Term Investments rose 41.9% year-over-year to $413.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $413.1 million (up 41.9% YoY) and the FY2025 annual result came in at $404.5 million, up 18.39% from the prior year.
  • Long-Term Investments was $413.1 million for Q1 2026 at Innoviva, up from $404.5 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $544.4 million in Q1 2022 and bottomed at $291.1 million in Q1 2025.
  • A 5-year average of $412.0 million and a median of $413.1 million in 2026 frame the typical range for Long-Term Investments.
  • Annual changes were most pronounced in 2025 — Long-Term Investments sank 38.91% — and 2026, when it soared 41.9%.
  • Innoviva's Long-Term Investments stood at $363.9 million in 2022, then rose by 22.14% to $444.4 million in 2023, then dropped by 23.12% to $341.7 million in 2024, then increased by 18.39% to $404.5 million in 2025, then increased by 2.12% to $413.1 million in 2026.
  • Business Quant data shows INVA's Long-Term Investments at $413.1 million in Q1 2026, $404.5 million in Q4 2025, and $343.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 505,194.89
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 9.79 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Innoviva 1.57 Bn 969.11 Mn 75.83 Mn 413.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 413.08 Mn
Dec 31, 2025 404.50 Mn
Sep 30, 2025 343.79 Mn
Jun 30, 2025 297.28 Mn
Mar 31, 2025 291.10 Mn
Dec 31, 2024 341.66 Mn
Sep 30, 2024 434.17 Mn
Jun 30, 2024 444.66 Mn
Mar 31, 2024 476.55 Mn
Dec 31, 2023 444.43 Mn
Sep 30, 2023 422.49 Mn
Jun 30, 2023 397.94 Mn
Mar 31, 2023 400.89 Mn
Dec 31, 2022 363.86 Mn
Sep 30, 2022 489.11 Mn
Jun 30, 2022 494.10 Mn
Mar 31, 2022 544.44 Mn
Dec 31, 2021 483.85 Mn
Sep 30, 2021 507.12 Mn
Jun 30, 2021 473.68 Mn